Bispecific antibody (BsAb) is a technology that has just been commercialized in the past ten years. However, its commercial prospect has already shown a bright outlook as BsAb has been considered a prospective drug for tumor and cancer treatment and a large number of projects in its research and development are underway.
At the same time, the Bispecific antibody (BsAb) research still faces challenges, such as mismatch, instability and imbalance in the expression of the two antibodies. As a supplier-of-choice for scientists across the globe, Creative Biolabs offers extensive service and product portfolio for BsAb research.
• BsAb Development Services
As a leading company in the antibody development market, experts in Creative Biolabs possess enriched experience in BsAb development and offer many different technical platforms and BsAb formats for customers.
For example, Creative Biolabs offers customized BsAb design services either for scientific research or clinical practice. Target-based BsAb design service can be aimed at different epitopes, ligands, receptors and immune cells. MOA-based BsAb design includes immune cell recruitment, signaling interference, forced protein associations, and payload delivery. Application-based BsAb design covers oncology, immunology, hematology, ophthalmology, osteology, pulmonary and respiratory diseases, pre-targeting systems, diagnostics, and gene therapy.
Another featured service is BsAb engineering. With decades of experience in antibody research, scientists at Creative Biolabs can engineer BsAb of different subtypes from various species, including bispecific IgGs, appended IgGs, bispecific antibody fragments, bispecific fusion proteins and bispecific antibody conjugates.
Creative Biolabs offers the most comprehensive BsAb development services with integrated pipelines, other services such as BsAb manufacturing and BsAb analysis are also available with the advanced technologies and suitable platforms.
• Custom BsAb Products
Creative Biolabs collects hot therapeutic targets and provides a variety of customized BsAb products. Based on the advanced strategies and to fit the desired target-product profile, a wide variety of BsAb has been developed to adapt the valency, structure, half-life and biodistribution, etc.
Featured BsAb products include but are not limited to Tandem scFv, Diabody, IgG-scFv, CrossMab, Triple Body, Single-chain Diabody, Minibody, Bispecific Immunotoxin, Constant Domain-extended Bispecific Fragments and Fab-scFv Fusion Proteins.
With novel strategies and proprietary Creative Discovery Platform™, Creative Biolabs provides comprehensive, end-to-end BsAb services and products to support related research. Further information can be found on https://www.creative-biolabs.com/bsab.
About Creative Biolabs
Established in 2004 by scientists who are dedicated to conquering of cancer, Creative Biolabs has grown into a recognized world leader in antibody (rAb) discovery, engineering, production, and analysis. The bispecific antibody (BsAb) team of Creative Biolabs has gathered a collective of experienced scientists committed to providing high-quality service to customers all over the world.